These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

363 related items for PubMed ID: 23326153

  • 1. Delayed liver laceration following transjugular intrahepatic portosystemic shunt for portal hypertension.
    Liu K, Fan XX, Wang XL, He CS, Wu XJ.
    World J Gastroenterol; 2012 Dec 28; 18(48):7405-8. PubMed ID: 23326153
    [Abstract] [Full Text] [Related]

  • 2. Reducing risk of transjugular intrahepatic portosystemic shunt using ultrasound guided single needle pass.
    Leong S, Kok HK, Govender P, Torreggiani W.
    World J Gastroenterol; 2013 Jun 14; 19(22):3528-30. PubMed ID: 23801852
    [Abstract] [Full Text] [Related]

  • 3. A patient with portal hypertension and blindness after transjugular intrahepatic portosystemic shunt.
    Appenrodt B, Schepke M, Kuntz-Hehner S, Schmiedel A, Sauerbruch T.
    Eur J Gastroenterol Hepatol; 2006 Apr 14; 18(4):447-9. PubMed ID: 16538120
    [Abstract] [Full Text] [Related]

  • 4. Transjugular intrahepatic portosystemic shunts and portal hypertension-related complications.
    Siramolpiwat S.
    World J Gastroenterol; 2014 Dec 07; 20(45):16996-7010. PubMed ID: 25493012
    [Abstract] [Full Text] [Related]

  • 5. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension.
    Colombato L.
    J Clin Gastroenterol; 2007 Dec 07; 41 Suppl 3():S344-51. PubMed ID: 17975487
    [Abstract] [Full Text] [Related]

  • 6. [Hemolytic anemia secondary to the placement of a portosystemic stented shunt].
    Carrillo-Esper R, Carrillo-Cortes U, Carrillo-Córdova JR, Carrillo-Córdova LD, Carrillo-Córdova CA, Carrillo-Córdova DM.
    Cir Cir; 2013 Dec 07; 81(2):143-7. PubMed ID: 23522316
    [Abstract] [Full Text] [Related]

  • 7. Transjugular intrahepatic portosystemic shunt for recompensating decompensated cirrhosis?
    Karagiannakis DS.
    World J Gastroenterol; 2024 May 28; 30(20):2621-2623. PubMed ID: 38855160
    [Abstract] [Full Text] [Related]

  • 8. Transjugular intrahepatic portosystemic shunt in patients with cirrhosis: Indications and posttransjugular intrahepatic portosystemic shunt complications in 2020.
    Horhat A, Bureau C, Thabut D, Rudler M.
    United European Gastroenterol J; 2021 Mar 28; 9(2):203-208. PubMed ID: 32819214
    [Abstract] [Full Text] [Related]

  • 9. Targeted puncture of left branch of intrahepatic portal vein in transjugular intrahepatic portosystemic shunt to reduce hepatic encephalopathy.
    Luo SH, Chu JG, Huang H, Zhao GR, Yao KC.
    World J Gastroenterol; 2019 Mar 07; 25(9):1088-1099. PubMed ID: 30862997
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Combined transjugular intrahepatic portosystemic shunt and other interventions for hepatocellular carcinoma with portal hypertension.
    Qiu B, Zhao MF, Yue ZD, Zhao HW, Wang L, Fan ZH, He FL, Dai S, Yao JN, Liu FQ.
    World J Gastroenterol; 2015 Nov 21; 21(43):12439-47. PubMed ID: 26604651
    [Abstract] [Full Text] [Related]

  • 13. Recanalization of an occluded intrahepatic portosystemic covered stent via the percutaneous transhepatic approach.
    Chan CY, Liang PC.
    Korean J Radiol; 2010 Nov 21; 11(4):469-71. PubMed ID: 20592931
    [Abstract] [Full Text] [Related]

  • 14. Reduction in portal venous pressure by transjugular intrahepatic portosystemic shunt for treatment of hemorrhagic stomal varices.
    Deipolyi AR, Kalva SP, Oklu R, Walker TG, Wicky S, Ganguli S.
    AJR Am J Roentgenol; 2014 Sep 21; 203(3):668-73. PubMed ID: 25148174
    [Abstract] [Full Text] [Related]

  • 15. Transjugular intrahepatic portosystemic shunt in cirrhosis: An exhaustive critical update.
    Rajesh S, George T, Philips CA, Ahamed R, Kumbar S, Mohan N, Mohanan M, Augustine P.
    World J Gastroenterol; 2020 Oct 07; 26(37):5561-5596. PubMed ID: 33088154
    [Abstract] [Full Text] [Related]

  • 16. Long-term effects and complications of the transjugular intrahepatic portosystemic shunt: a single-centre experience.
    Kraglund F, Jepsen P, Amanavicius N, Aagaard NK.
    Scand J Gastroenterol; 2019 Jul 07; 54(7):899-904. PubMed ID: 31203699
    [Abstract] [Full Text] [Related]

  • 17. Transjugular intrahepatic portal shunt in the treatment of portal hypertension due to cirrhosis: single center experience.
    Chen Y, Qiu H, Zhang X.
    BMC Surg; 2019 Dec 12; 19(1):191. PubMed ID: 31830972
    [Abstract] [Full Text] [Related]

  • 18. CXCL9 is a prognostic marker in patients with liver cirrhosis receiving transjugular intrahepatic portosystemic shunt.
    Berres ML, Asmacher S, Lehmann J, Jansen C, Görtzen J, Klein S, Meyer C, Strunk HM, Fimmers R, Tacke F, Strassburg CP, Trautwein C, Sauerbruch T, Wasmuth HE, Trebicka J.
    J Hepatol; 2015 Feb 12; 62(2):332-9. PubMed ID: 25457205
    [Abstract] [Full Text] [Related]

  • 19. Pre-emptive transjugular intrahepatic portosystemic shunt in pediatric cystic fibrosis-related liver disease and portal hypertension: prospective long-term results.
    Hermie L, Biervliet SV, Hoorens A, Cauwenberghe LV, Robberecht E, Defreyne L.
    Diagn Interv Radiol; 2024 Jan 08; 30(1):55-64. PubMed ID: 36994654
    [Abstract] [Full Text] [Related]

  • 20. Using transjugular intrahepatic portosystemic shunts for complications of cirrhosis.
    Bhogal HK, Sanyal AJ.
    Clin Gastroenterol Hepatol; 2011 Nov 08; 9(11):936-46; quiz e123. PubMed ID: 21699820
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.